FORT LAUDERDALE, Fla., March 14, 2012 /PRNewswire/ -- Nouveau Life Pharmaceuticals, soon to be changed from Hybrid Fuels, Inc. (Pink Sheets: HRID), announced today that it has received positive coverage from Advent Financial, a leading financial analyst group focused on small and micro-cap companies. Advent has a very qualified team of research analysts with extensive experience at large investment banks including Bank of America, Goldman Sachs, and UBS Warburg.
As published in the report under the Financial Projections & Valuation section, "We estimate revenue to reach $42 million by FY2016. Our valuation analysis suggests that the stock can be valued as high as $0.88 per share."
To view the report in its entirety, please visit: http://www.adventfinancialinc.com/research/index.php under recent reports.
About Azul Instant
Azul Instant was developed by the scientific research and development team of Nouveau Life Pharmaceuticals to provide a safe and natural alternative for the millions of men suffering from erectile dysfunction. The Company's goal is to create the healthiest and most effective all-natural male enhancer ever formulated. Patients will now receive the NATURAL benefits of Azul Instant and unlike pharmaceutical drugs such as Cialis, Viagra and Levitra, Azul Instant carries no dangerous side effects. While there are other natural alternative supplements on the market today, Azul Instant is the only male enhancement product that works as fast as 5 minutes. Azul Instant can last for up to 48 hours and has proven to help enhance sexual stamina, endurance, strength and energy with no side effects.
Azul Instant is marketed under Nouveau Life Pharmaceuticals, Inc. For more information, go to www.azulnow.com.
About Hybrid Fuels, Inc.
The company was incorporated in the state of Nevada in 1998 as Polo Equities. It has primarily been a development stage company with management focused on developing innovative business opportunities and further advancing technologies.
Forward-Looking Statements - This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that could cause future results to differ materially from the forward-looking statements. You should consider these factors in evaluating the statements herein, and not rely on such statements. The forward-looking statements in this release are made as of the date hereof and Hybrid Fuels, Inc. undertakes no obligation to update such statements.
CONTACT:
Nouveau Life Pharmaceuticals, Inc. - 954-903-2993
SOURCE Nouveau Life Pharmaceuticals, Inc.